Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis
Journal of Hematology · 2024-04 · 13 (1-2) · 46-51
DOI: 10.14740/jh1242 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Hematology, 2024-04. Verfasst von Chun Li Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
- Division of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
- Division of Medical Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Zitieren
APA
Yang, C. L., Chen, X., Zhou, H. J., Wu, W. C., & Zou, L. Q. (2024). Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis. Journal of Hematology, 13(1-2), 46-51. https://doi.org/10.14740/jh1242
Vancouver
Yang CL, Chen X, Zhou HJ, Wu WC, Zou LQ. Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis. Journal of Hematology. 2024;13(1-2):46-51. doi:10.14740/jh1242
BibTeX
@article{Yang2024,
author = {Yang, Chun Li and Chen, Xi and Zhou, Hui Jie and Wu, Wan Chun and Zou, Li Qun},
title = {Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis},
journal = {Journal of Hematology},
year = {2024},
volume = {13},
number = {1-2},
pages = {46--51},
doi = {10.14740/jh1242}
}
EUVIMED